A. Capelastegui

1.5k total citations
32 papers, 912 citations indexed

About

A. Capelastegui is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medicine. According to data from OpenAlex, A. Capelastegui has authored 32 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Epidemiology and 8 papers in Emergency Medicine. Recurrent topics in A. Capelastegui's work include Pneumonia and Respiratory Infections (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Emergency and Acute Care Studies (8 papers). A. Capelastegui is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Emergency and Acute Care Studies (8 papers). A. Capelastegui collaborates with scholars based in Spain, United States and Russia. A. Capelastegui's co-authors include José M. Quintana, Mikel Egurrola, Pedro Pablo España, Amaia Bilbao, Inmaculada Gorordo, Myriam Aburto, Cristóbal Esteban, Javier Moraza, Julio Pérez‐Izquierdo and Susana Aizpiri and has published in prestigious journals such as Neurology, European Respiratory Journal and Thorax.

In The Last Decade

A. Capelastegui

29 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Capelastegui Spain 14 459 357 213 152 116 32 912
Luis Borderías Spain 23 817 1.8× 579 1.6× 209 1.0× 213 1.4× 259 2.2× 72 1.5k
Carmen Puzo Spain 14 436 0.9× 515 1.4× 112 0.5× 281 1.8× 89 0.8× 35 946
Inmaculada Alfageme Spain 22 559 1.2× 1.1k 3.1× 129 0.6× 195 1.3× 330 2.8× 90 1.6k
Naoufel Madani Morocco 13 192 0.4× 214 0.6× 97 0.5× 187 1.2× 30 0.3× 28 780
Pedro J. Marcos Spain 15 285 0.6× 330 0.9× 70 0.3× 112 0.7× 93 0.8× 72 885
Alma C. van de Pol Netherlands 16 497 1.1× 214 0.6× 80 0.4× 107 0.7× 42 0.4× 37 844
Austin Ugwumadu United Kingdom 19 443 1.0× 391 1.1× 108 0.5× 27 0.2× 60 0.5× 58 1.6k
J. Hedlund Sweden 18 950 2.1× 169 0.5× 146 0.7× 152 1.0× 25 0.2× 31 1.2k
Theodore W. Marcy United States 20 128 0.3× 862 2.4× 267 1.3× 131 0.9× 250 2.2× 31 1.2k
Helen A. Dickie United States 17 215 0.5× 547 1.5× 75 0.4× 92 0.6× 136 1.2× 37 1.1k

Countries citing papers authored by A. Capelastegui

Since Specialization
Citations

This map shows the geographic impact of A. Capelastegui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Capelastegui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Capelastegui more than expected).

Fields of papers citing papers by A. Capelastegui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Capelastegui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Capelastegui. The network helps show where A. Capelastegui may publish in the future.

Co-authorship network of co-authors of A. Capelastegui

This figure shows the co-authorship network connecting the top 25 collaborators of A. Capelastegui. A scholar is included among the top collaborators of A. Capelastegui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Capelastegui. A. Capelastegui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Capelastegui, A., et al.. (2025). Efficacy of indocyanine green-guided lymphatic mapping in the gastric cancer lymphadenectomy: impact of neoadjuvant chemotherapy. Cirugía Española (English Edition). 103(9). 800158–800158.
3.
Ruiz, Luis Alberto, Rafael Zalacaín, A. Capelastegui, et al.. (2014). Bacteremic Pneumococcal Pneumonia in Elderly and Very Elderly Patients: Host- and Pathogen-Related Factors, Process of Care, and Outcome. The Journals of Gerontology Series A. 69(8). 1018–1024. 12 indexed citations
4.
Capelastegui, A., José M. Quintana, Amaia Bilbao, et al.. (2012). Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission. European Journal of Clinical Microbiology & Infectious Diseases. 31(10). 2693–2701. 7 indexed citations
5.
España, Pedro Pablo, A. Capelastegui, Amaia Bilbao, et al.. (2012). Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 31(12). 3397–3405. 29 indexed citations
6.
Menéndez, Rosario, Antoni Torres, S. Reyes, et al.. (2011). Initial management of pneumonia and sepsis: factors associated with improved outcome. European Respiratory Journal. 39(1). 156–162. 59 indexed citations
7.
Esteban, Cristóbal, Inmaculada Aróstegui, Javier Moraza, et al.. (2011). Development of a decision tree to assess the severity and prognosis of stable COPD. European Respiratory Journal. 38(6). 1294–1300. 45 indexed citations
8.
Esteban, Cristóbal, José M. Quintana, Myriam Aburto, et al.. (2010). Impact of changes in physical activity on health-related quality of life among patients with COPD. European Respiratory Journal. 36(2). 292–300. 149 indexed citations
9.
Capelastegui, A., Pedro Pablo España, José M. Quintana, et al.. (2009). Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia. Thorax. 64(6). 496–501. 15 indexed citations
10.
Esteban, Cristóbal, José M. Quintana, Myriam Aburto, Javier Moraza, & A. Capelastegui. (2006). A simple score for assessing stable chronic obstructive pulmonary disease. QJM. 99(11). 751–759. 43 indexed citations
11.
Capelastegui, A., et al.. (2006). Seguridad en resonancia magnética: análisis basado en una revisión de incidentes en Osatek. Radiología. 48(4). 225–234. 1 indexed citations
12.
Capelastegui, A., et al.. (2005). Patients Hospitalized With Community-Acquired Pneumonia: a Comparative Study of Outcomes by Medical Specialty Area. Archivos de Bronconeumología. 41(6). 300–306. 4 indexed citations
13.
Urrutia, Isabel, A. Capelastegui, José M. Quintana, et al.. (2004). Association Between the Forced Midexpiratory Flow/Forced Vital Capacity Ratio and Bronchial Hyperresponsiveness. Archivos de Bronconeumología. 40(9). 397–402. 8 indexed citations
14.
Moraza, Javier, et al.. (2003). Normalización de las cifras de presión en la arteria pulmonar tras tratamiento efectivo de la enfermedad de Graves. Archivos de Bronconeumología. 39(1). 45–47. 4 indexed citations
15.
España, Pedro Pablo, A. Capelastegui, José M. Quintana, et al.. (2003). A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. European Respiratory Journal. 21(4). 695–701. 51 indexed citations
16.
Esteban, Cristóbal, Javier Moraza, Myriam Aburto, José M. Quintana, & A. Capelastegui. (2003). Descripción de una muestra de pacientes con enfermedad pulmonar obstructiva crónica atendidos en las consultas del área de neumología dependientes de un hospital. Archivos de Bronconeumología. 39(11). 485–490. 15 indexed citations
17.
Capelastegui, A., et al.. (2000). MR Findings in Pulmonary Hypertrophic Osteoarthropathy. Clinical Radiology. 55(1). 72–75. 16 indexed citations
18.
Capelastegui, A., et al.. (1999). Masses and pseudomasses of the hand and wrist: MR findings in 134 cases. Skeletal Radiology. 28(9). 498–507. 61 indexed citations
19.
Capelastegui, A., et al.. (1999). Atypical MRI presentation of a small splenic hamartoma. European Radiology. 9(5). 883–885. 10 indexed citations
20.
Capelastegui, A., et al.. (1994). Bronquiectasias: etiopatogenia y métodos diagnósticos. Archivos de Bronconeumología. 30(3). 153–162. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Borderías Breakdown of academic impact, for papers by Carmen Puzo Breakdown of academic impact, for papers by Inmaculada Alfageme Breakdown of academic impact, for papers by Naoufel Madani Breakdown of academic impact, for papers by Pedro J. Marcos Breakdown of academic impact, for papers by Alma C. van de Pol Breakdown of academic impact, for papers by Austin Ugwumadu Breakdown of academic impact, for papers by J. Hedlund Breakdown of academic impact, for papers by Theodore W. Marcy Breakdown of academic impact, for papers by Helen A. Dickie
Rankless by CCL
2026